News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Gilead Sciences, Inc.
NEWS
JOBS
IN THE PRESS
NEWS
Deals
3 Reasons Why Gilead Will Buy Incyte—and 1 Reason Why It Won’t
March 15, 2017
·
1 min read
Deals
3 M&A Scenarios For Gilead
March 14, 2017
·
1 min read
Deals
What a Gilead-Incyte Marriage Would Look Like
March 14, 2017
·
2 min read
Deals
Rumors Surface M&A-Desperate Gilead is Nearing a Deal to Buy Incyte
March 13, 2017
·
3 min read
Biotech Bay
How The Repeal Of Obamacare Could Put $270 Million Back In Gilead’s Bank Account
March 10, 2017
·
1 min read
Biotech Bay
3 Things Gilead Can Do To Return To Its Glory Days
March 8, 2017
·
1 min read
Deals
Gilead: Buy The HIV Franchise And Get The Rest For Almost Free
February 28, 2017
·
1 min read
Business
Drug Giants Like AbbVie, Bristol-Myers Squibb and Gilead Turn to Well-Known Professors to Justify Its Outrageous Drug Prices
February 24, 2017
·
1 min read
Biotech Bay
3 Things Gilead’ CEO Just Said That You’ll Want to Know
February 23, 2017
·
1 min read
JOBS
Currently, there are no jobs for this company on BioSpace
Browse all jobs
here
Oops!
There was an issue retrieving the jobs list. Please reload the page to view more jobs.
Title
Location
Company Name
Desc
View details
IN THE PRESS
Business
Gilead Announces First Quarter 2017 Financial Results
May 3, 2017
·
1 min read
Business
Gilead Announces Second Quarter 2017 Dividend
May 3, 2017
·
1 min read
Drug Development
Gilead Announces Scientific Presentations Demonstrating Efficacy Of Harvoni (Ledipasvir/Sofosbuvir) In Special Patient Populations With HCV Infection
April 24, 2017
·
8 min read
Drug Development
Gilead Announces Scientific Presentations Demonstrating Efficacy Of Harvoni (Ledipasvir/Sofosbuvir) In Special Patient Populations With HCV Infection
April 21, 2017
·
8 min read
Drug Development
Gilead Presents Data At The International Liver Congress 2017 Supporting The Efficacy And Safety Of Vemlidy In Patients With Chronic Hepatitis B After 96 Weeks, And Also After Switching From Viread
April 21, 2017
·
9 min read
Drug Development
Gilead Presents Proof-Of-Concept Data For GS-0976 In Nonalcoholic Steatohepatitis (NASH) At The International Liver Congress 2017
April 21, 2017
·
5 min read
Drug Development
Gilead Presents Data At The International Liver Congress 2017 Supporting The Efficacy And Safety Of Vemlidy In Patients With Chronic Hepatitis B After 96 Weeks, And Also After Switching From Viread
April 20, 2017
·
9 min read
Drug Development
Gilead To Present Clinical And Preclinical Data On Nonalcoholic Steatohepatitis (NASH) At The International Liver Congress 2017
April 20, 2017
·
6 min read
Business
Gilead To Release First Quarter 2017 Financial Results On Tuesday, May 2, 2017
April 19, 2017
·
1 min read
Business
Gilead Building Hangzhou Manufacturing Facility
April 7, 2017
·
1 min read
